Literature DB >> 1212559

Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.

M Endoh.   

Abstract

1 Experiments were carried out on dog isolated papillary muscle and sinus node preparations perfused with arterial blood from a donor dog. The chronotropic and inotropic effects of dopamine were analysed by using reserpine, desmethylimipramine (DMI), cocaine and phenoxybenzamine, and the relative chronotropic and inotropic effects defined, the results being compared with those for noradrenaline (NA). 2 The effects of dopamine administered intra-arterially into the isolated preparations were reduced by pretreatment of animals with reserpine both in the papillary muscle and sinus node. The chronotropic effects, however, were affected less by pretreatment with reserpine than were the inotropic effects. 3 Desmethylimipramine (DMI) reduced the inotropic and chronotropic effects of dopamine, and enhanced the effects of NA and nerve stimulation; the chronotropic effects of the amines were less affected than the inotropic effects. 4 Cocaine enhanced considerably the inotropic and chronotropic effects of NA, and decreased the inotropic but not the chronotropic effect of dopamine. 5 Phenoxybenzamine enhanced the inotropic effects of dopamine, NA and nerve stimulation, but did not affect the chronotropic effects of the amines. 6 When dopamine (1 to 300 mug/kg) was administered intravenously to the donor dog, it increased preferentially the contractile force of the ventricular myocardium with a comparatively small change of the sinus rate in the isolated preparations as well as in the heart in vivo. NA (0.1 to 10 mug/kg) caused effects similar to those of dopamine. The maximal inotropic responses to these catecholamines were reached with lower doses than the chronotropic ones. 7 It is concluded that both the positive inotropic and the positive chronotropic responses to dopamine are mediated partially by a direct and partially by an indirect stimulant effect on beta-adrenoceptors in the dog heart. The present results suggest that the difference in activity of dopamine and NA between the ventricular myocardium and the sinus node may be ascribed to the unequal innervation with adrenergic nerve fibres of the atrium and the ventricle (Furnival, Linden & Snow, 1971). The sinus node which is densely innervated by adrenergic nerve fibres may inactivate noradrenaline and dopamine more effectively than the ventricular myocardium through the uptake into the nerve and thereby be less sensitive to the exogenous catecholamines.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1212559      PMCID: PMC1666739          DOI: 10.1111/j.1476-5381.1975.tb07422.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  MECHANISM OF CARDIAC ACTIVITIES SYMPATHOMIMETIC AMINES ON ISOLATED AURICLES OF RABBITS.

Authors:  W C LEE; C S YOO
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-09-01

2.  Comparative study of chronotropic effects of catecholamines and tyramine on the SA node of the dog heart in situ.

Authors:  S Chiba; H Hashimoto; K Hashimoto
Journal:  Jpn J Pharmacol       Date:  1973-06

3.  Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.

Authors:  K Hashimoto; M Endoh; K Tamura; N Taira
Journal:  Experientia       Date:  1970

4.  Responses of the sino-atrial node to change in pressure in the sinus node artery.

Authors:  K Hashimoto; S Tanaka; M Hirata; S Chiba
Journal:  Circ Res       Date:  1967-09       Impact factor: 17.367

5.  On the cardiovascular action of dopamine in rats.

Authors:  P J Neuvonen; E Westermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Study of the therapeutic and toxic effects of ouabain by simultaneous observations on the excised and blood-perfused sinoatrial node and papillary muscle preparations and the in situ heart of dogs.

Authors:  K Hashimoto; T Kimura; K Kubota
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

7.  Interactions of guanethidine and indirect-acting sympathomimetic amines.

Authors:  K Starke
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-02

8.  Effects of perivascular nerve stimulation on the contraction and automaticity of the blood-perfused canine papillary muscle.

Authors:  M Endoh; K Hashimoto; T Kimura
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

9.  Inotropic changes in the left ventricle: the effect of changes in heart rate, aortic pressure and end-diastolic pressure.

Authors:  C M Furnival; R J Linden; H M Snow
Journal:  J Physiol       Date:  1970-12       Impact factor: 5.182

10.  The inotropic and chronotropic effects of catecholamines on the dog heart.

Authors:  C M Furnival; R J Linden; H M Snow
Journal:  J Physiol       Date:  1971-04       Impact factor: 5.182

View more
  5 in total

1.  The pharmacology and subacute toxicology of dopamine.

Authors:  J F Zaroslinski; L H Possley; R A Schwartz; R N Morris; F A Carone; R K Browne
Journal:  Proc R Soc Med       Date:  1977

2.  Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog.

Authors:  M Endoh; T Shimizu; T Yanagisawa
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

3.  Direct and indirect actions of dopamine on tracheal smooth muscle.

Authors:  Y Koga; H Downes; S M Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

4.  Dopamine in the conscious dog with chronic heart-block. Mechanisms of chronotropic cardiac effects.

Authors:  M Boucher; C Dubray; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

5.  Consequences of peripheral chemoreflex inhibition with low-dose dopamine in humans.

Authors:  Piotr Niewinski; Stanislaw Tubek; Waldemar Banasiak; Julian F R Paton; Piotr Ponikowski
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.